Dr. Ken Spielvogel

Uterine cancer, absolutely.

And for men, prostate cancer, gastrointestinal cancer.

So now you have a drug that's going to control weight.

It's going to reduce that down.

That's going to increase your insulin sensitivity, which in turn is going to lower inflammation.

Lower inflammation in the body is going to equal less of a chance of cancer.

Okay.

Alzheimer's disease, dementia, new data coming out.

Ongoing trials that say that probably you have a reduced risk of plaque formation in the brain.

Plaque formation is what we find in radiographic studies showing Alzheimer's disease and dementia.

You're kidding.

No.

So if you get a diagnosis of dementia, of Alzheimer's disease, and you're 60 years old.

It's like getting a stage four cancer diagnosis.

There ain't shit you can do about it.

You can try to slow the progress of it, but you got that diagnosis.

What you do now is what's going to prevent that from occurring.

GLP-1 potentially for, you know, I could sit here and say probably everyone would benefit from it, even in a microdose.

I think that's where we're going to land in some way, but reduces that risk of plaque formation.

Then we move to the fourth one, metabolic disease.